JP2017519784A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017519784A5 JP2017519784A5 JP2016575488A JP2016575488A JP2017519784A5 JP 2017519784 A5 JP2017519784 A5 JP 2017519784A5 JP 2016575488 A JP2016575488 A JP 2016575488A JP 2016575488 A JP2016575488 A JP 2016575488A JP 2017519784 A5 JP2017519784 A5 JP 2017519784A5
- Authority
- JP
- Japan
- Prior art keywords
- linked
- pharmaceutical composition
- composition according
- optionally substituted
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FYGSULGPSNHJFD-LUTQBAROSA-N C#C[C@@]([C@@H]1O)([C@H]([n]2c(N=C(N)NC3=O)c3nc2)O[C@@]1(COP(O)(OP(O)(OP(O)(O)=O)=O)=O)F)F Chemical compound C#C[C@@]([C@@H]1O)([C@H]([n]2c(N=C(N)NC3=O)c3nc2)O[C@@]1(COP(O)(OP(O)(OP(O)(O)=O)=O)=O)F)F FYGSULGPSNHJFD-LUTQBAROSA-N 0.000 description 1
- MAYPBRYPGCIUGY-FPQZTECRSA-N CC([C@@]([C@@H]1F)([C@H]([n]2c(N=C(N)NC3=O)c3nc2)O[C@@]1(COP(O)(OP(O)(OP(O)(O)=O)=O)=O)F)O)=C Chemical compound CC([C@@]([C@@H]1F)([C@H]([n]2c(N=C(N)NC3=O)c3nc2)O[C@@]1(COP(O)(OP(O)(OP(O)(O)=O)=O)=O)F)O)=C MAYPBRYPGCIUGY-FPQZTECRSA-N 0.000 description 1
- GRVAKIGJYFCAOR-LGVRLFTQSA-N CCOc1c2nc[n]([C@@H]([C@]3(C)F)OCC3(COP(NC(C)C(OC(C)C)=O)(Oc3ccccc3)=O)O)c2nc(N)n1 Chemical compound CCOc1c2nc[n]([C@@H]([C@]3(C)F)OCC3(COP(NC(C)C(OC(C)C)=O)(Oc3ccccc3)=O)O)c2nc(N)n1 GRVAKIGJYFCAOR-LGVRLFTQSA-N 0.000 description 1
- POYJEGXPYNEDOC-OUVAMTEUSA-N CCOc1nc(N)nc2c1nc[n]2[C@@H]([C@@](C)([C@@H]1F)O)O[C@@]1(COP(OCOC(OC(C)C)=O)(OCOC(OC(C)C)=O)=O)F Chemical compound CCOc1nc(N)nc2c1nc[n]2[C@@H]([C@@](C)([C@@H]1F)O)O[C@@]1(COP(OCOC(OC(C)C)=O)(OCOC(OC(C)C)=O)=O)F POYJEGXPYNEDOC-OUVAMTEUSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462016232P | 2014-06-24 | 2014-06-24 | |
| US62/016,232 | 2014-06-24 | ||
| US201462061770P | 2014-10-09 | 2014-10-09 | |
| US62/061,770 | 2014-10-09 | ||
| PCT/US2015/037001 WO2015200219A1 (en) | 2014-06-24 | 2015-06-22 | Substituted nucleosides, nucleotides and analogs thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020114136A Division JP7080928B2 (ja) | 2014-06-24 | 2020-07-01 | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017519784A JP2017519784A (ja) | 2017-07-20 |
| JP2017519784A5 true JP2017519784A5 (enExample) | 2018-09-13 |
| JP6728075B2 JP6728075B2 (ja) | 2020-07-22 |
Family
ID=54868668
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016575488A Expired - Fee Related JP6728075B2 (ja) | 2014-06-24 | 2015-06-22 | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
| JP2020114136A Expired - Fee Related JP7080928B2 (ja) | 2014-06-24 | 2020-07-01 | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
| JP2022085181A Active JP7449978B2 (ja) | 2014-06-24 | 2022-05-25 | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020114136A Expired - Fee Related JP7080928B2 (ja) | 2014-06-24 | 2020-07-01 | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
| JP2022085181A Active JP7449978B2 (ja) | 2014-06-24 | 2022-05-25 | 置換ヌクレオシド、ヌクレオチドおよびその類似体 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US9603864B2 (enExample) |
| EP (2) | EP3797782A1 (enExample) |
| JP (3) | JP6728075B2 (enExample) |
| CN (2) | CN117379452A (enExample) |
| AU (2) | AU2015280248B2 (enExample) |
| CA (2) | CA3207106A1 (enExample) |
| DK (1) | DK3160476T3 (enExample) |
| EA (1) | EA201692535A1 (enExample) |
| ES (1) | ES2841310T3 (enExample) |
| HR (1) | HRP20202014T1 (enExample) |
| HU (1) | HUE051986T2 (enExample) |
| IL (1) | IL249628A0 (enExample) |
| LT (1) | LT3160476T (enExample) |
| MX (1) | MX2016017383A (enExample) |
| PH (1) | PH12016502564A1 (enExample) |
| SG (1) | SG11201610599TA (enExample) |
| SI (1) | SI3160476T1 (enExample) |
| SM (1) | SMT202000716T1 (enExample) |
| TW (1) | TW201613612A (enExample) |
| WO (1) | WO2015200219A1 (enExample) |
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2524356T3 (es) | 2010-07-22 | 2014-12-05 | Gilead Sciences, Inc. | Métodos y compuestos para tratar infecciones provocadas por virus Paramyxoviridae |
| SG10201610936RA (en) | 2011-12-22 | 2017-02-27 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| US8980865B2 (en) | 2011-12-22 | 2015-03-17 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US8916538B2 (en) | 2012-03-21 | 2014-12-23 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9598457B2 (en) | 2012-12-21 | 2017-03-21 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| GEP201706757B (en) * | 2012-12-21 | 2017-10-25 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| AU2014248116A1 (en) | 2013-04-05 | 2015-11-12 | Alios Biopharma, Inc. | Hepatitis C viral infection treatment using a combination of compounds |
| EP3424938B1 (en) | 2013-06-26 | 2020-07-22 | Janssen BioPharma, Inc. | 4'-azidoalkyl-substituted nucleosides, nucleotides and analogs thereof |
| HK1224229A1 (zh) | 2013-06-26 | 2017-08-18 | Alios Biopharma, Inc. | 取代的核苷，核苷酸及其类似物 |
| JP6562908B2 (ja) * | 2013-10-11 | 2019-08-21 | ヤンセン バイオファーマ インク． | 置換ヌクレオシド、置換ヌクレオチドおよびその類似体 |
| TN2016000566A1 (en) | 2014-06-24 | 2018-04-04 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| HUE051986T2 (hu) | 2014-06-24 | 2021-04-28 | Janssen Biopharma Inc | Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra |
| BR112017006264A2 (pt) | 2014-09-26 | 2017-12-12 | Riboscience Llc | derivados de nucleosídeo substituído com 4?-vinila como inibidores de replicação de rna do vírus sincitial respiratório |
| HK1243714A1 (zh) | 2014-10-28 | 2018-07-20 | Alios Biopharma, Inc. | 制备取代的核苷类似物的方法 |
| MA41441A (fr) | 2014-12-19 | 2017-12-12 | Alios Biopharma Inc | Nucléosides substitués, nucléotides et analogues de ceux-ci |
| MA41213A (fr) | 2014-12-19 | 2017-10-24 | Alios Biopharma Inc | Nucléosides substitués, nucléotides et analogues de ceux-ci |
| IL296496B2 (en) | 2014-12-26 | 2024-10-01 | Univ Emory | N4-hydroxycytidine and derivatives and anti-viral uses related thereto |
| GEP20217282B (en) | 2015-03-06 | 2021-08-10 | Atea Pharmaceuticals Inc | β-D-2'-DEOXY-2'α-FLUORO-2'-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT |
| EA036776B1 (ru) | 2015-03-11 | 2020-12-21 | Янссен Байофарма, Инк. | Соединения азапиридона и способы их применения |
| CN105503787A (zh) * | 2015-12-31 | 2016-04-20 | 阜阳欣奕华材料科技有限公司 | 一种索非布韦中间体的纯化方法 |
| CN109311885A (zh) * | 2016-03-24 | 2019-02-05 | 诺华股份有限公司 | 炔基核苷类似物作为人类鼻病毒的抑制剂 |
| JP7129703B2 (ja) * | 2016-04-28 | 2022-09-02 | エモリー ユニバーシティー | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 |
| US10202412B2 (en) | 2016-07-08 | 2019-02-12 | Atea Pharmaceuticals, Inc. | β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections |
| PT3512863T (pt) | 2016-09-07 | 2022-03-09 | Atea Pharmaceuticals Inc | Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna |
| TWI767937B (zh) | 2016-09-09 | 2022-06-21 | 美商卡利泰拉生物科技公司 | 外核苷酸酶抑制劑及其使用方法 |
| CA3047373A1 (en) * | 2016-12-16 | 2018-06-21 | Gifu University | Nucleoside derivative and use thereof |
| CN110248951B (zh) | 2017-02-01 | 2022-10-28 | 阿堤亚制药公司 | 用于治疗丙型肝炎病毒的核苷酸半硫酸盐 |
| WO2018204198A1 (en) | 2017-05-01 | 2018-11-08 | Gilead Sciences, Inc. | Crystalline forms of (s) 2 ethylbutyl 2 (((s) (((2r,3s,4r,5r) 5 (4 aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)methoxy)(phenoxy) phosphoryl)amino)propanoate |
| EP4512475A3 (en) | 2017-07-11 | 2025-05-14 | Gilead Sciences, Inc. | Compositions comprising an rna polymerase inhibitor and cyclodextrin for treating viral infections |
| US11306111B2 (en) | 2017-07-31 | 2022-04-19 | January Therapeutics, Inc. | Organophosphate derivatives |
| CA3075950A1 (en) * | 2017-09-18 | 2019-03-21 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| WO2019088179A1 (ja) | 2017-10-31 | 2019-05-09 | ヤマサ醤油株式会社 | ヌクレオシド誘導体及びその利用 |
| KR102626210B1 (ko) | 2017-12-07 | 2024-01-18 | 에모리 유니버시티 | N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도 |
| WO2019169323A1 (en) * | 2018-03-02 | 2019-09-06 | January Therapeutics, Inc. | Nanoparticle compositions |
| IL277160B2 (en) * | 2018-03-07 | 2024-10-01 | Univ Emory | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| WO2019200005A1 (en) | 2018-04-10 | 2019-10-17 | Atea Pharmaceuticals, Inc. | Treatment of hcv infected patients with cirrhosis |
| EP3934760A1 (en) | 2019-03-06 | 2022-01-12 | GlaxoSmithKline Intellectual Property (No.2) Limited | Compounds useful in hiv therapy |
| EP3950696A4 (en) * | 2019-04-05 | 2023-01-04 | Nippon Shokubai Co., Ltd. | PRODUCTION OF BRIDGE ARTIFICIAL NUCLEOSIDE |
| JP2022551477A (ja) * | 2019-10-08 | 2022-12-09 | エモリー ユニバーシティー | ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用 |
| AU2021214911A1 (en) | 2020-01-27 | 2022-07-21 | Gilead Sciences, Inc. | Methods for treating SARS CoV-2 infections |
| AU2021224588B2 (en) * | 2020-02-18 | 2024-07-18 | Gilead Sciences, Inc. | Antiviral compounds |
| TWI794742B (zh) | 2020-02-18 | 2023-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| TWI874791B (zh) | 2020-02-18 | 2025-03-01 | 美商基利科學股份有限公司 | 抗病毒化合物 |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| CN113387954B (zh) * | 2020-03-11 | 2024-03-19 | 上海特化医药科技有限公司 | 一种瑞德西韦中间体的制备方法 |
| CN118994170A (zh) | 2020-03-12 | 2024-11-22 | 吉利德科学公司 | 制备1'-氰基核苷的方法 |
| CA3169348A1 (en) | 2020-03-20 | 2021-09-23 | Gilead Sciences, Inc. | Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same |
| CN115335387A (zh) * | 2020-03-27 | 2022-11-11 | 住友化学株式会社 | 核酸寡聚物的制造方法 |
| ES3037416T3 (en) * | 2020-03-27 | 2025-10-01 | R G C C Holdings Ag | Compounds for the in vitro inhibition of the rna-dependent rna polymerase of coronaviruses |
| EP4132651B1 (en) | 2020-04-06 | 2026-03-18 | Gilead Sciences, Inc. | Inhalation formulations of 1'-cyano substituted carbanucleoside analogs |
| AU2021255809A1 (en) * | 2020-04-14 | 2022-12-15 | Janssen Pharmaceuticals, Inc. | Bi- and monocyclic nucleoside analogs for treatment of hepatitis E |
| ES3041698T3 (en) | 2020-05-29 | 2025-11-13 | Gilead Sciences Inc | Remdesivir for the treatment of viral infections |
| CA3187821A1 (en) | 2020-06-24 | 2021-12-30 | Gilead Sciences, Inc. | 1'-cyano nucleoside analogs and uses thereof |
| MX2023002233A (es) | 2020-08-24 | 2023-03-15 | Gilead Sciences Inc | Compuestos fosfolipidos y usos de estos. |
| WO2022047065A2 (en) | 2020-08-27 | 2022-03-03 | Gilead Sciences, Inc. | Compounds and methods for treatment of viral infections |
| TWI811812B (zh) | 2020-10-16 | 2023-08-11 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
| CN112279877B (zh) * | 2020-12-15 | 2021-08-06 | 南京颐媛生物医学研究院有限公司 | 一种核苷磷酸酯及其合成方法 |
| CN113214320A (zh) * | 2021-01-23 | 2021-08-06 | 河南泰丰生物科技有限公司 | 一种瑞德西韦化合物的制备方法 |
| WO2022174194A1 (en) * | 2021-02-15 | 2022-08-18 | Emory University | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| KR20240006536A (ko) * | 2021-04-09 | 2024-01-15 | 에모리 유니버시티 | 항바이러스제로서의 티오뉴클레오시드 |
| JP7688152B2 (ja) | 2021-04-16 | 2025-06-03 | ギリアード サイエンシーズ， インコーポレイテッド | アミドを使用してカルバヌクレオシドを調製する方法 |
| BR112023026356A2 (pt) | 2021-06-17 | 2024-03-05 | Atea Pharmaceuticals Inc | Método para tratar vírus da hepatite c ou uma condição resultante de uma infecção por hepatite c, combinação, uso da combinação, composição farmacêutica, e, kit para o tratamento de vírus da hepatite c |
| CA3224494A1 (en) | 2021-07-09 | 2023-01-12 | Koen Vandyck | Anti-viral compounds |
| CN113735929A (zh) * | 2021-07-21 | 2021-12-03 | 海化生命(厦门)科技有限公司 | 一种抗冠状病毒的化合物及其制备方法与应用 |
| JP7719954B2 (ja) | 2021-08-18 | 2025-08-06 | ギリアード サイエンシーズ， インコーポレイテッド | リン脂質化合物並びにその製造方法及び使用方法 |
| CN115721661A (zh) * | 2021-09-01 | 2023-03-03 | 常晓宇 | 嘌呤核苷类药物预防或治疗冠状病毒感染性疾病的用途 |
| CN113461760B (zh) * | 2021-09-06 | 2021-12-10 | 南京颐媛生物医学研究院有限公司 | 4-硫代脱氧胸苷衍生物及其抗乙肝病毒制药应用 |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
| EP4419536A4 (en) * | 2021-10-19 | 2026-04-15 | Alnylam Pharmaceuticals Inc | 2'-DEOXY-2'-F-2'-C-METHYL NUCLEOTIDES |
| US11541071B1 (en) | 2021-12-16 | 2023-01-03 | Ascletis BioScience Co., Ltd | Nucleoside derivatives and methods of use thereof |
| CN116554249B (zh) * | 2022-01-28 | 2025-03-18 | 北京恩泰伟医药科技有限公司 | 抗病毒化合物及其用途 |
| TW202525810A (zh) | 2022-03-02 | 2025-07-01 | 美商基利科學股份有限公司 | 用於治療病毒感染的化合物及方法 |
| EP4493573A1 (en) | 2022-03-15 | 2025-01-22 | Rome Therapeutics, Inc. | Compounds and methods for treating disease |
| US20250282812A1 (en) * | 2022-04-20 | 2025-09-11 | Shanghai Institute Of Materia Medica , Chinese Academy Of Sciences | Antiviral nucleoside analogue, and pharmaceutical composition and use thereof |
| US20260115216A1 (en) * | 2022-08-10 | 2026-04-30 | Kyushu University, National University Corporation | Nucleic acid precursor |
| WO2024086592A2 (en) * | 2022-10-17 | 2024-04-25 | Emory Unversity | 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
| US12357577B1 (en) | 2024-02-02 | 2025-07-15 | Gilead Sciences, Inc. | Pharmaceutical formulations and uses thereof |
| CN116589510B (zh) * | 2023-04-20 | 2025-08-26 | 安徽大学 | 一种氟代苄基核糖中间体的制备方法与应用 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5432272A (en) | 1990-10-09 | 1995-07-11 | Benner; Steven A. | Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases |
| JP2004533406A (ja) * | 2000-10-18 | 2004-11-04 | フアーマセツト・リミテツド | ウイルス感染症および異常細胞増殖を治療するための修飾ヌクレオシド |
| SI1355916T1 (sl) | 2001-01-22 | 2007-04-30 | Merck & Co Inc | Nukleozidni derivati kot inhibitorji RNA-odvisne RNA virusne polimeraze |
| PT1523489E (pt) * | 2002-06-28 | 2014-06-24 | Centre Nat Rech Scient | Profármacos de nucleósido modificado em 2' e 3' para tratamento de infecções por flaviridae |
| US20040259934A1 (en) * | 2003-05-01 | 2004-12-23 | Olsen David B. | Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds |
| EP1656093A2 (en) * | 2003-05-14 | 2006-05-17 | Idenix (Cayman) Limited | Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses |
| WO2005020885A2 (en) * | 2003-05-21 | 2005-03-10 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| JP2008508319A (ja) | 2004-07-29 | 2008-03-21 | メタバシス・セラピューティクス・インコーポレイテッド | 新規ヌクレオシド誘導体 |
| US7951789B2 (en) | 2006-12-28 | 2011-05-31 | Idenix Pharmaceuticals, Inc. | Compounds and pharmaceutical compositions for the treatment of viral infections |
| CA2679257C (en) * | 2007-02-28 | 2017-04-04 | The Governors Of The University Of Alberta | Compounds for preventing or treating viral infections and methods of use thereof |
| AR072906A1 (es) | 2008-08-06 | 2010-09-29 | Novartis Ag | Nucleosidos modificados utiles como antivirales |
| AU2010226466A1 (en) * | 2009-03-20 | 2011-10-20 | Alios Biopharma, Inc. | Substituted nucleoside and nucleotide analogs |
| US20100240604A1 (en) * | 2009-03-20 | 2010-09-23 | Alios Biopharma, Inc. | Protected nucleotide analogs |
| GEP20156313B (en) | 2010-09-22 | 2015-07-10 | Alios Biopharma Inc | Substituted nucleotide analogs |
| EP2619215B1 (en) | 2010-09-22 | 2018-09-05 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| WO2012040126A1 (en) * | 2010-09-22 | 2012-03-29 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| CN102558261A (zh) * | 2010-12-17 | 2012-07-11 | 中国科学院大连化学物理研究所 | 一种核苷酸类似物及其合成和应用 |
| EP2655392B1 (en) | 2010-12-22 | 2018-04-18 | Alios Biopharma, Inc. | Cyclic nucleotide analogs |
| BR112013029761A2 (pt) * | 2011-05-19 | 2017-03-21 | Univ Emory | pró-drogas de monofosfato de purina para tratamento de infecções virais |
| UA111761C2 (uk) | 2011-12-20 | 2016-06-10 | Рібосаєнс Ллс | 2',4'-дифтор-2'-метилзаміщені нуклеозидні похідні як інгібітори реплікації phk вірусу гепатиту c |
| SG10201610936RA (en) | 2011-12-22 | 2017-02-27 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| US8980865B2 (en) | 2011-12-22 | 2015-03-17 | Alios Biopharma, Inc. | Substituted nucleotide analogs |
| RS58437B1 (sr) | 2012-03-21 | 2019-04-30 | Alios Biopharma Inc | Supstituisani nukleozidi, nukleotidi i njihovi analozi |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| HK1203513A1 (en) | 2012-03-21 | 2015-10-30 | 艾丽奥斯生物制药有限公司 | Methods of preparing substituted nucleotide analogs |
| WO2013142159A1 (en) | 2012-03-21 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
| US8916538B2 (en) | 2012-03-21 | 2014-12-23 | Vertex Pharmaceuticals Incorporated | Solid forms of a thiophosphoramidate nucleotide prodrug |
| EP2827876A4 (en) | 2012-03-22 | 2015-10-28 | Alios Biopharma Inc | PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG |
| EP2935304A1 (en) | 2012-12-19 | 2015-10-28 | IDENIX Pharmaceuticals, Inc. | 4'-fluoro nucleosides for the treatment of hcv |
| FR3000193B1 (fr) | 2012-12-20 | 2015-01-16 | Msc & Sgcc | Procede et dispositif de mesure de la verticalite sur un recipient |
| GEP201706757B (en) | 2012-12-21 | 2017-10-25 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| US9598457B2 (en) | 2012-12-21 | 2017-03-21 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| TW201526899A (zh) | 2013-02-28 | 2015-07-16 | Alios Biopharma Inc | 醫藥組成物 |
| WO2014164533A1 (en) | 2013-03-11 | 2014-10-09 | Vertex Pharmaceuticals Incorporated | Methods of stereoselective synthesis of substituted nucleoside analogs |
| AU2014248116A1 (en) | 2013-04-05 | 2015-11-12 | Alios Biopharma, Inc. | Hepatitis C viral infection treatment using a combination of compounds |
| BR112015025766A2 (pt) * | 2013-04-12 | 2017-10-17 | Achillion Pharmaceuticals Inc | derivado de nucleosídeo altamente ativo para o tratamento de hcv |
| HK1224229A1 (zh) | 2013-06-26 | 2017-08-18 | Alios Biopharma, Inc. | 取代的核苷，核苷酸及其类似物 |
| EP3424938B1 (en) | 2013-06-26 | 2020-07-22 | Janssen BioPharma, Inc. | 4'-azidoalkyl-substituted nucleosides, nucleotides and analogs thereof |
| DK3043803T3 (da) * | 2013-09-11 | 2022-08-01 | Univ Emory | Nukleotid- og nucleosidsammensætninger og deres anvendelse |
| JP6562908B2 (ja) | 2013-10-11 | 2019-08-21 | ヤンセン バイオファーマ インク． | 置換ヌクレオシド、置換ヌクレオチドおよびその類似体 |
| BR112016029994A2 (pt) | 2014-06-24 | 2017-08-22 | Alios Biopharma Inc | métodos de preparação de análogos de nucleotídeo substituídos |
| HUE051986T2 (hu) | 2014-06-24 | 2021-04-28 | Janssen Biopharma Inc | Helyettesített nukleozidok, nukleotidek és analógjaik virális fertõzés kezelésére való alkalmazásra |
| TN2016000566A1 (en) | 2014-06-24 | 2018-04-04 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| JP2017525681A (ja) | 2014-07-22 | 2017-09-07 | アリオス バイオファーマ インク． | パラミクソウイルスの治療方法 |
| JP2017523988A (ja) | 2014-08-05 | 2017-08-24 | アリオス バイオファーマ インク． | パラミクソウイルスを治療するための併用療法 |
| HK1243714A1 (zh) | 2014-10-28 | 2018-07-20 | Alios Biopharma, Inc. | 制备取代的核苷类似物的方法 |
| MA41441A (fr) | 2014-12-19 | 2017-12-12 | Alios Biopharma Inc | Nucléosides substitués, nucléotides et analogues de ceux-ci |
| MA41213A (fr) | 2014-12-19 | 2017-10-24 | Alios Biopharma Inc | Nucléosides substitués, nucléotides et analogues de ceux-ci |
| US20190169221A1 (en) | 2016-08-12 | 2019-06-06 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| WO2018081449A1 (en) | 2016-10-27 | 2018-05-03 | Alios Biopharma, Inc. | Methods for treating respiratory syncytial virus infection |
-
2015
- 2015-06-22 HU HUE15812231A patent/HUE051986T2/hu unknown
- 2015-06-22 CN CN202310927143.6A patent/CN117379452A/zh active Pending
- 2015-06-22 EA EA201692535A patent/EA201692535A1/ru unknown
- 2015-06-22 DK DK15812231.7T patent/DK3160476T3/da active
- 2015-06-22 AU AU2015280248A patent/AU2015280248B2/en not_active Ceased
- 2015-06-22 LT LTEP15812231.7T patent/LT3160476T/lt unknown
- 2015-06-22 SM SM20200716T patent/SMT202000716T1/it unknown
- 2015-06-22 CN CN201580045439.9A patent/CN106573011A/zh active Pending
- 2015-06-22 ES ES15812231T patent/ES2841310T3/es active Active
- 2015-06-22 WO PCT/US2015/037001 patent/WO2015200219A1/en not_active Ceased
- 2015-06-22 SI SI201531469T patent/SI3160476T1/sl unknown
- 2015-06-22 US US14/746,500 patent/US9603864B2/en active Active
- 2015-06-22 HR HRP20202014TT patent/HRP20202014T1/hr unknown
- 2015-06-22 EP EP20192890.0A patent/EP3797782A1/en not_active Ceased
- 2015-06-22 MX MX2016017383A patent/MX2016017383A/es unknown
- 2015-06-22 SG SG11201610599TA patent/SG11201610599TA/en unknown
- 2015-06-22 JP JP2016575488A patent/JP6728075B2/ja not_active Expired - Fee Related
- 2015-06-22 EP EP15812231.7A patent/EP3160476B1/en active Active
- 2015-06-22 CA CA3207106A patent/CA3207106A1/en active Pending
- 2015-06-22 CA CA2952966A patent/CA2952966C/en active Active
- 2015-06-24 TW TW104120371A patent/TW201613612A/zh unknown
-
2016
- 2016-12-18 IL IL249628A patent/IL249628A0/en unknown
- 2016-12-21 PH PH12016502564A patent/PH12016502564A1/en unknown
-
2017
- 2017-02-02 US US15/423,270 patent/US10307439B2/en active Active
-
2020
- 2020-07-01 JP JP2020114136A patent/JP7080928B2/ja not_active Expired - Fee Related
-
2021
- 2021-07-08 AU AU2021204791A patent/AU2021204791B2/en not_active Ceased
-
2022
- 2022-05-25 JP JP2022085181A patent/JP7449978B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020172511A5 (enExample) | ||
| JP2012521359A5 (enExample) | ||
| MX384836B (es) | Agentes antivirales contra la hepatitis b | |
| JP2025098020A5 (enExample) | ||
| PH12020550065A1 (en) | Hepatitis b antiviral agents | |
| HRP20202014T1 (hr) | Supstituirani nukleozidi, nukleotidi i njihovi analozi za uporabu u liječenju virusne infekcije | |
| CY1114892T1 (el) | Φαρμακευτικη συνθεση ενος ισχυρου αναστολεα του hcv για απο του στοματος χορηγηση | |
| MX372775B (es) | Derivados de cumarina y métodos de uso en el tratamiento de la fribosis quística, enfermedad pulmonar obstructiva crónica y trastornos de proteínas mal plegadas. | |
| BR112012003578A8 (pt) | Composto, sal farmaceuticamente aceitável, sal de sulfato, composição farmacêutica, método para tratar uma infecção viral, e, uso de um composto ou sal | |
| JP2015510946A5 (enExample) | ||
| JP2014515038A5 (enExample) | ||
| WO2019143902A3 (en) | Substituted heterocycles as antiviral agents | |
| CY1118726T1 (el) | Αναστολεις αντιγραφης ιων γριπης | |
| RU2014133818A (ru) | Стабилизированный состав pth | |
| MX2010006209A (es) | Derivados de quinoxalinilo. | |
| JP2017518334A5 (enExample) | ||
| SG10201407013QA (en) | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | |
| CA2753382C (en) | Hepatitis c virus inhibitors | |
| EA201291301A1 (ru) | Производные 2-хинолинилуксусной кислоты в качестве противовирусных соединений против вич | |
| JP2015518055A5 (enExample) | ||
| JP2013537907A5 (enExample) | ||
| JP2016006096A5 (enExample) | ||
| TN2012000358A1 (en) | Hepatitis c virus inhibitors | |
| EA026667B9 (ru) | Фармацевтическая композиция для лечения вируса гепатита с | |
| EP2555622A4 (en) | HEPATITIS C-VIRUS HEMMER |